There are two main methods of liver cancer treatment. One is surgical treatment and the other is non-surgical treatment. Surgery is mainly for early-stage liver cancer. The concept of early-stage liver cancer used to refer to patients with tumors below 5 centimeters, but now it usually refers to patients with tumors below 3 centimeters, and the treatment effect for these patients is very good. For patients who cannot be surgically removed, that is, patients with advanced tumor or early stage tumor but combined with medical diseases, such as heart disease or hypertension, etc., these medical factors and patients with severe liver cirrhosis, who cannot afford surgery, can use other non-surgical treatment methods. Among the non-surgical treatment methods, interventional treatment should be more mature at present. In addition to interventional treatment, there are also radiation therapy and systemic chemotherapy, and other palliative treatments. Some readers may ask: There are different types of hepatocellular carcinoma, so how to choose the treatment method? Pathologically, hepatocellular carcinoma is divided into hepatocellular carcinoma, cholangiocellular carcinoma, and mixed type. Hepatocellular hepatocellular carcinoma accounts for most of the cases. Hepatocellular hepatocellular carcinoma is characterized by rich blood supply and is most suitable for interventional treatment. The indications for interventional therapy are firstly, the tumor is rich in blood supply. Cholangiocellular carcinoma is not rich in blood supply due to its special biological behavior, and at the same time, cholangiocellular carcinoma is not very sensitive to chemotherapy and radiotherapy, so the effect of interventional therapy is very limited because the blood supply is not rich and embolization cannot be done well and the blood vessels cannot be blocked. From this perspective, interventional treatment for liver cancer is mainly for hepatocellular liver cancer, but for cholangiocellular liver cancer, because radiotherapy and chemotherapy are not very sensitive, if patients cannot be surgically removed, radiotherapy and chemotherapy are not very effective at present, and this group of patients is also doing interventional treatment. Although interventional therapy cannot achieve the same ideal effect as hepatocellular liver cancer for this group of patients, it can still slow down the progress of patients’ disease.